Estée Lauder(US:EL) 新华网财经·2025-10-31 09:05Core Viewpoint - Breast cancer is the most common malignant tumor among women globally, with increasing incidence and mortality rates in China, highlighting the urgent need for early screening and prevention efforts [2][5][11]. Group 1: Breast Cancer Statistics and Trends - Breast cancer ranks second in incidence and fifth in mortality among female malignancies in China, with a trend of increasing rates and younger onset [2]. - The "Healthy China 2030" initiative emphasizes the importance of improving screening and early diagnosis rates for common diseases among women [2]. Group 2: Corporate Social Responsibility Initiatives - Estée Lauder Group has been deeply involved in breast cancer prevention since introducing the "Pink Ribbon" in China in 2003, establishing various charitable projects [5][11]. - The group has raised over $144 million for breast cancer research, education, screening, and treatment, with plans to donate 10 million RMB to support the "Breast Health Care Project" over three years [11]. Group 3: Community Engagement and Education - The "Pink Ribbon" initiative has evolved from a symbol of charity to a comprehensive health ecosystem, engaging various community outreach activities, including health lectures and screening programs [8][10]. - The group has developed a multi-faceted approach to public engagement, utilizing social media and in-store experiences to lower barriers for public participation in health initiatives [10]. Group 4: Future Directions and Goals - The company aims to continue enhancing its network of support for breast cancer prevention and treatment, advocating for long-term commitment to public health initiatives rather than short-term marketing strategies [14][15]. - The ongoing efforts are aligned with the broader goal of achieving a "Healthy China" and moving towards a world without breast cancer [15].